GHRS logo

GHRS
GH Research PLC

659
Mkt Cap
$921.14M
Volume
195,531.00
52W High
$19.51
52W Low
$7.98
PE Ratio
-20.31
GHRS Fundamentals
Price
$14.85
Prev Close
$15.63
Open
$15.41
50D MA
$15.03
Beta
0.94
Avg. Volume
696,027.75
EPS (Annual)
-$0.7488
P/B
3.16
Rev/Employee
$0.00
$215.50
Loading...
Loading...
News
all
press releases
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments PR Newswire VANCOUVER, BC, Feb. 27...
PR Newswire·2d ago
News Placeholder
More News
News Placeholder
GH Research (NASDAQ:GHRS) Shares Up 8.8% - Should You Buy?
GH Research (NASDAQ:GHRS) Shares Up 8.8% - Time to Buy...
MarketBeat·12d ago
News Placeholder
GH Research PLC (NASDAQ:GHRS) Receives Consensus Rating of "Moderate Buy" from Analysts
GH Research PLC (NASDAQ:GHRS - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve ratings firms that are presently covering the stock, MarketBeat.com reports. One...
MarketBeat·1mo ago
News Placeholder
GH Research (NASDAQ:GHRS) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
Royal Bank Of Canada lifted their price target on GH Research from $33.00 to $40.00 and gave the stock an "outperform" rating in a research report on Friday...
MarketBeat·1mo ago
News Placeholder
GH Research (NASDAQ:GHRS) Stock Price Down 7.5% - Here's What Happened
GH Research (NASDAQ:GHRS) Stock Price Down 7.5% - Should You Sell...
MarketBeat·1mo ago
News Placeholder
GH Research (NASDAQ:GHRS) Stock Price Down 9.2% - Should You Sell?
GH Research (NASDAQ:GHRS) Stock Price Down 9.2% - Should You Sell...
MarketBeat·2mo ago
News Placeholder
GH Research (NASDAQ:GHRS) Shares Gap Up - Time to Buy?
GH Research (NASDAQ:GHRS) Shares Gap Up - Should You Buy...
MarketBeat·2mo ago
News Placeholder
Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday
read more...
Benzinga·2mo ago
News Placeholder
FDA Lifts Hold On GH Research's Depression Drug Trial After Two Years
The FDA lifted its clinical hold on GH Research's GH001 after Phase 2b data showed rapid, durable benefits in treatment-resistant depression, clearing the path toward Phase 3 trials planned for...
Benzinga·2mo ago
News Placeholder
Why Is GHRS Stock Rising Today?
GH Research stated that the FDA has cleared GH001 for a clinical investigation in the U.S.
Stocktwits·2mo ago
<
1
2
...
>

Latest GHRS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.